Jambuwala Pharmaceuticals Limited, a active public limited company, was established on 17 August 2017 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100GJ2017PLC098725. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.10 Cr and a paid-up capital of ₹6.09 Cr.
It upholds a compliant status. Employing 37 professional, Its leadership includes Pranlal Bhailal Shah (Director), Rasilaben Pranlal Shah (Director), Kamal Pranlal Shah (Director). Past directors included Hiren Vijaykumar Doshi, Chintan Pranlal Shah, Rasilaben Pranlal Shah. It holds ₹10.60 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Subplot C-19,20,21,22, Gallops Ind. Park2, Nh-8A Ahmd-Rajkot Highway Chachrawadi Vasna, S, Anand, Ahmedabad, Gujarat, 382213.
U24100GJ2017PLC098725
098725
17 August 2017
₹6.10 Cr
₹6.09 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Jambuwala Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pranlal Bhailal Shah | Director | 17 Aug 2017 | Current |
| Rasilaben Pranlal Shah | Director | 17 Aug 2024 | Current |
| Kamal Pranlal Shah | Director | 17 Aug 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2020 | Past |
| Pramod Abcsdd | Director | 23 Aug 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jambuwala Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 66.03% increase. The company also saw a substantial fall in profitability, with a 67.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Jambuwala Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹105,984,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Mar 2019 | Sidbi | ₹10.60 Cr | Open |
Explore comprehensive loan charge details -
Jambuwala Pharmaceuticals has a workforce of 37 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jambuwala Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jambuwala Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jambuwala Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Rasilaben Pranlal Shah was appointed as a Director was appointed as a Director on 17 Aug 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
The activity Jambuwala Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity A charge with Sidbi of Rs. 10.60 Cr registered on 01 Mar 2019 with Charge ID 100251220 was modified on 28 Mar 2024. was completed.
Progress on A charge with Sidbi amounted to Rs. 10.60 Cr with Charge ID 100251220 was registered on 01 Mar 2019. was documented.
The activity Pranlal Bhailal Shah was appointed as a Director was appointed as a Director on 17 Aug 2017 & has been associated with this company since 8 years 4 months . was completed.
The CIN of Jambuwala Pharmaceuticals Limited is U24100GJ2017PLC098725.
Jambuwala Pharmaceuticals Limited is headquartered at Subplot C-19,20,21,22, Gallops Ind. Park2, Nh-8A Ahmd-Rajkot Highway Chachrawadi Vasna, S, Anand, Ahmedabad, Gujarat, 382213.
Jambuwala Pharmaceuticals Limited was incorporated on 17 August 2017.
The current directors of Jambuwala Pharmaceuticals Limited are
The primary industry of Jambuwala Pharmaceuticals Limited is Manufacturing.
Jambuwala Pharmaceuticals Limited is unlisted.
The authorized capital of Jambuwala Pharmaceuticals Limited is ₹6.10 Cr, and the paid-up capital is ₹6.09 Cr.
The compliance status of Jambuwala Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX